MedTrace Logo

Role of NFKBIA and PTPN22 Genes Polymorphism in Acute Rejection Susceptibility After Living Donor Liver Transplantation in Egyptian Patients.

NCT06060808 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2023-09-29

No results posted yet for this study

Summary

Our study aimed at studying the impact of gene polymorphism of NFKBIA and PTPN22 genes on rejection episodes in liver transplant Egyptian recipients. Also assess patients' factors associated with graft rejection.

Conditions

  • Liver Transplant Rejection

Interventions

GENETIC

gene polymorphism

gene polymorphism of NFKBIA and PTPN22 genes

Sponsors & Collaborators

  • Helwan University

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-15
Primary Completion
2023-04-23
Completion
2023-07-24

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06060808 on ClinicalTrials.gov